| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1469-0691.2010.03250.X |
| P953 | full work available at URL | http://www.clinicalmicrobiologyandinfection.com/article/S1198743X1461733X/pdf |
| https://api.elsevier.com/content/article/PII:S1198743X1461733X?httpAccept=text/plain | ||
| https://api.elsevier.com/content/article/PII:S1198743X1461733X?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 20880409 |
| P5875 | ResearchGate publication ID | 46819733 |
| P2093 | author name string | A. Oliver | |
| A. Mena | |||
| P2860 | cites work | Adaptive radiation in a heterogeneous environment | Q56038387 |
| Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
| Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
| Hypermutability Impedes Cooperation in Pathogenic Bacteria | Q57933645 | ||
| Epidemiology Of Chronic Pseudomonas aeruginosa Infections In Cystic Fibrosis | Q59334968 | ||
| Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence | Q61477540 | ||
| Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis | Q61477562 | ||
| Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance | Q79162727 | ||
| Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease | Q79805323 | ||
| Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis | Q80385327 | ||
| Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis | Q84219534 | ||
| The effect of elevated mutation rates on the evolution of cooperation and virulence of Pseudomonas aeruginosa | Q84417552 | ||
| Proliferation of mutators in A cell population | Q35618973 | ||
| Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. | Q35879111 | ||
| Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro | Q36095041 | ||
| Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation | Q36295397 | ||
| Endogenous oxidative stress produces diversity and adaptability in biofilm communities | Q36858633 | ||
| The microbiology of mutability | Q36917147 | ||
| Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa | Q36933558 | ||
| Stress-induced mutagenesis in bacteria. | Q36961683 | ||
| Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains | Q37421041 | ||
| Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections | Q37598703 | ||
| Self-generated diversity produces "insurance effects" in biofilm communities | Q37621081 | ||
| Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy | Q37788421 | ||
| PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. | Q38309969 | ||
| The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates | Q38898519 | ||
| Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. | Q39606842 | ||
| High frequency of mutator strains among human uropathogenic Escherichia coli isolates. | Q39694657 | ||
| Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. | Q39743496 | ||
| Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients | Q39955018 | ||
| The GO system prevents ROS-induced mutagenesis and killing in Pseudomonas aeruginosa | Q40324438 | ||
| SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. | Q40943537 | ||
| Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion | Q40968218 | ||
| Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation | Q41366386 | ||
| Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital | Q41462681 | ||
| Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation | Q41825397 | ||
| Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. | Q41937031 | ||
| Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
| Inactivation of the mismatch repair system in Pseudomonas aeruginosa attenuates virulence but favors persistence of oropharyngeal colonization in cystic fibrosis mice. | Q42560500 | ||
| Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections. | Q42909082 | ||
| Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants | Q43153453 | ||
| Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants | Q43216787 | ||
| Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa | Q43264873 | ||
| Mismatch repair and the regulation of phase variation in Neisseria meningitidis | Q43612705 | ||
| Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test | Q43627836 | ||
| Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? | Q43874264 | ||
| High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains | Q44195004 | ||
| Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum | Q45044337 | ||
| Fitness of an Escherichia coli Mutator Gene | Q45158915 | ||
| Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. | Q46002328 | ||
| Spontaneous mutators in bacteria: insights into pathways of mutagenesis and repair | Q46617407 | ||
| Increased mutability of Pseudomonas aeruginosa in biofilms | Q46767850 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Inactivation of mismatch repair increases the diversity of Vibrio parahaemolyticus | Q48071446 | ||
| Interspecies gene exchange in bacteria: the role of SOS and mismatch repair systems in evolution of species. | Q50144938 | ||
| Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. | Q50452988 | ||
| Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. | Q52575837 | ||
| MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa. | Q52579021 | ||
| Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis. | Q54485886 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Dynamics of Pseudomonas aeruginosa genome evolution | Q24652525 | ||
| Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer | Q28257360 | ||
| The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
| Characterization of the GO system of Pseudomonas aeruginosa | Q28492940 | ||
| Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
| Mismatch repair in replication fidelity, genetic recombination, and cancer biology | Q29616483 | ||
| Lung infections associated with cystic fibrosis | Q30080000 | ||
| Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa. | Q30974317 | ||
| Mutator genes giving rise to decreased antibiotic susceptibility in Pseudomonas aeruginosa | Q33355731 | ||
| The Pseudomonas aeruginosa pfpI gene plays an antimutator role and provides general stress protection | Q33386642 | ||
| Role of mutation in Pseudomonas aeruginosa biofilm development. | Q33482815 | ||
| Escherichia coli mutator genes | Q33539352 | ||
| Population structure, antimicrobial resistance, and mutation frequencies of Streptococcus pneumoniae isolates from cystic fibrosis patients. | Q33859051 | ||
| Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori | Q33952076 | ||
| Selection for high mutation rates in chemostats | Q33989687 | ||
| Amplification of mutator cells in a population as a result of horizontal transfer | Q33996324 | ||
| Mutator clones of Neisseria meningitidis in epidemic serogroup A disease | Q34028018 | ||
| Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes | Q34248249 | ||
| Evolution of high mutation rates in experimental populations of E. coli | Q34429727 | ||
| Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family | Q34502921 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa | Q34509793 | ||
| Experimental adaptation of Salmonella typhimurium to mice | Q34569582 | ||
| Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis | Q34588476 | ||
| Specialized DNA polymerases, cellular survival, and the genesis of mutations | Q34662609 | ||
| Coevolution with viruses drives the evolution of bacterial mutation rates. | Q34722064 | ||
| Mutation and evolution of antibiotic resistance: antibiotics as promoters of antibiotic resistance? | Q34725726 | ||
| Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate | Q34975227 | ||
| The role of mutators in the emergence of antibiotic-resistant bacteria | Q35177659 | ||
| Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis | Q35557791 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| antibiotic resistance | Q380775 | ||
| DNA mismatch repair | Q2984243 | ||
| P304 | page(s) | 798-808 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Clinical Microbiology and Infection | Q15757285 |
| P1476 | title | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance | |
| P478 | volume | 16 |
| Q40120799 | A Genotypic Analysis of Five P. aeruginosa Strains after Biofilm Infection by Phages Targeting Different Cell Surface Receptors. |
| Q36668852 | A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence |
| Q36586859 | A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections |
| Q51489925 | A trade-off between oxidative stress resistance and DNA repair plays a role in the evolution of elevated mutation rates in bacteria. |
| Q35816112 | Acinetobacter baumannii Repeatedly Evolves a Hypermutator Phenotype in Response to Tigecycline That Effectively Surveys Evolutionary Trajectories to Resistance |
| Q59807739 | Adaptation, speciation and extinction in the Anthropocene |
| Q36369411 | An analogy between the evolution of drug resistance in bacterial communities and malignant tissues |
| Q39474102 | Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients |
| Q36757725 | Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? |
| Q30336845 | Archetypal analysis of diverse Pseudomonas aeruginosa transcriptomes reveals adaptation in cystic fibrosis airways |
| Q38103942 | Bacterial genome evolution within a clonal population: from in vitro investigations to in vivo observations |
| Q39010188 | Burkholderia cepacia Complex Regulation of Virulence Gene Expression: A Review |
| Q41908656 | Characterization of rough and smooth morphotypes of Mycobacterium abscessus isolates from clinical specimens |
| Q38207078 | Chronic pulmonary pseudomonal infection in patients with cystic fibrosis: A model for early phase symbiotic evolution |
| Q34948367 | Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. |
| Q35914177 | Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model |
| Q35350270 | Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. |
| Q45973870 | Comparative physiological study of the wild type and the small colony variant of Pseudomonas aeruginosa 20265 under controlled growth conditions. |
| Q41255353 | Contribution of increased mutagenesis to the evolution of pollutants-degrading indigenous bacteria |
| Q36213685 | Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. |
| Q85110286 | Cystic fibrosis: deciphering the complexity |
| Q37627287 | Darwinism for the Genomic Age: Connecting Mutation to Diversification |
| Q29346787 | Deep sequencing analyses expands the Pseudomonas aeruginosa AmpR regulon to include small RNA-mediated regulation of iron acquisition, heat shock and oxidative stress response |
| Q56875376 | Directed evolution of Escherichia coli with lower-than-natural plasmid mutation rates |
| Q45962906 | DnaN clamp zones provide a platform for spatiotemporal coupling of mismatch detection to DNA replication. |
| Q90148668 | Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection |
| Q37896674 | Emergence and spread of antibiotic resistance following exposure to antibiotics |
| Q57052032 | Emergence and within-host genetic evolution of methicillin-resistant resistant to linezolid in a cystic fibrosis patient |
| Q91711760 | Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission |
| Q37248273 | Evolution of Ecological Diversity in Biofilms of Pseudomonas aeruginosa by Altered Cyclic Diguanylate Signaling |
| Q30243898 | Evolution, genomics and epidemiology of Pseudomonas syringae: Challenges in Bacterial Molecular Plant Pathology. |
| Q34557099 | Evolutionary dynamics and genomic features of the Elizabethkingia anophelis 2015 to 2016 Wisconsin outbreak strain |
| Q38417030 | Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients |
| Q36187249 | General and inducible hypermutation facilitate parallel adaptation in Pseudomonas aeruginosa despite divergent mutation spectra. |
| Q37691811 | Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q36337074 | Global fluoroquinolone resistance epidemiology and implictions for clinical use. |
| Q37922538 | Hypermutation and stress adaptation in bacteria |
| Q58098483 | Hypermutation-induced in vivo oxidative stress resistance enhances Vibrio cholerae host adaptation |
| Q37510338 | Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients |
| Q37349255 | Long-Term Evolution of Burkholderia multivorans during a Chronic Cystic Fibrosis Infection Reveals Shifting Forces of Selection |
| Q93128945 | Microbial population dynamics under microdoses of the essential oil arborvitae |
| Q34998656 | Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices. |
| Q91902524 | Mutation bias and GC content shape antimutator invasions |
| Q34550797 | Mutational spectrum drives the rise of mutator bacteria |
| Q36075893 | Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins. |
| Q48202022 | NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection. |
| Q36887819 | Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa |
| Q90223032 | Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor |
| Q34297656 | Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients |
| Q41822095 | Population structure and antimicrobial susceptibility of both nonpersistent and persistent Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients |
| Q27001070 | Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung |
| Q64065367 | Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins |
| Q35006748 | Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis |
| Q38273318 | Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. |
| Q37643058 | Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence |
| Q35084559 | Pseudomonas aeruginosa: resistance to the max |
| Q35758927 | Quorum quenching quandary: resistance to antivirulence compounds |
| Q36018436 | Rapid Acquisition of Linezolid Resistance in Methicillin-Resistant Staphylococcus aureus: Role of Hypermutation and Homologous Recombination |
| Q37263761 | Rapid emergence of resistance to linezolid and mutator phenotypes in Staphylococcus aureus isolates from an adult cystic fibrosis patient. |
| Q55085798 | Regulatory protein SrpA controls phage infection and core cellular processes in Pseudomonas aeruginosa. |
| Q42717931 | Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa |
| Q28703592 | Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease |
| Q30576045 | Strain-specific parallel evolution drives short-term diversification during Pseudomonas aeruginosa biofilm formation |
| Q34298758 | The Agr quorum-sensing system regulates fibronectin binding but not hemolysis in the absence of a functional electron transport chain. |
| Q38023386 | The challenges and promises of new therapies for cystic fibrosis |
| Q35885995 | The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa |
| Q37385372 | The unpluggable in pursuit of the undruggable: tackling the dark matter of the cancer therapeutics universe |
| Q27010697 | Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis |
| Q36101044 | Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis |
| Q62899027 | Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre |
Search more.